Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
COMBACTE COMBACTE
deeptech, Research Services
Other

24 Nov 2022

6 Nov 2022



Tribune de Lyon Tribune de Lyon
Newspaper Publishing
Other

18 Jan 2018


Evolem Evolem
Financial Services, edtech
Other

27 Feb 2018


EFPIA - European Federation of Pharmaceutical Industries and Associations EFPIA - European Federation of Pharmaceutical Industries and Associations
biotech, deeptech, Pharmaceutical Manufacturing
Other

10 Nov 2020


La Tribune Afrique La Tribune Afrique
Newspaper Publishing
Other

26 Sep 2019


SAE Media Group SAE Media Group
Events Services
Other

9 Jun 2020


Cooperación Internacional - IYC Cooperación Internacional - IYC
civictech, Non-profit Organizations
Other

18 Dec 2019

31 Dec 2022



HueDx HueDx
biotech, deeptech, Biotechnology Research
Capitalistic
Not partnership
Not event

13 Apr 2018


eHealth Africa eHealth Africa
it services, healthtech, Non-profit Organizations
Other

9 Sep 2019


Da Volterra Da Volterra
biotech, deeptech, Biotechnology Research
Not capitalistic
Not partnership
Event

19 Jan 2017


Radars
Loading...